Table 4.
Antibiotic resistance pattern of Gram-negative bacterial isolates among HIV/AIDS patients at Felege Hiwot Referral Hospital.
| Gram-negative | Antibiotic susceptibility pattern | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| CIP, | COT, | AMP, | AMC, | CRO, | CN, | TE, | C, | PI, | |
| N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
| K. pneumoniae (n = 19) | |||||||||
| S | 19 (100) | 12 (63) | 2 (10.5) | 14 (73.6) | 19 (100) | 8 (42) | 1 (5) | 16 (84.2) | — |
| I | 0 (0) | 0 (0) | 0 (0) | 1 (5.3) | 0 (0) | 1 (5.3) | 0 (0) | 0 (0) | — |
| R | 0 (0) | 7 (37) | 17 (89) | 4 (21) | 0 (0) | 10 (53) | 18 (95) | 3 (16) | — |
| K. rhinoscleromatis (n = 3) | |||||||||
| S | 2 (67) | 2 (67) | 1 (33.3) | 2 (66.7) | 3 (100) | 3 (100) | 0 (0) | 3 (100) | — |
| R | 1 (33) | 1 (33) | 2 (66.7) | 1 (33.3) | 0 (0) | 0 (0) | 3 (100) | 0 (0) | — |
| E. aerogenes (n = 16) | |||||||||
| S | 14 (87.5) | 6 (37.5) | 1 (6.3) | 10 (62.5) | 15 (93.7) | 6 (37.5) | 1 (6.25) | 16 (100) | — |
| I | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (6.2) | 2 (12.5) | 0 (0) | — |
| R | 2 (12.5) | 10 (62.5) | 15 (93.7) | 6 (37.5) | 1 (6.3) | 9 (56.2) | 13 (81.3) | 0 (0) | — |
| Haemophilus spp. (n = 3) | |||||||||
| S | 3 (100) | 1 (33.3) | 0 (0) | 2 (66.7) | 3 (100) | 2 (66.7) | 0 (0) | 3 (100) | — |
| R | 0 (0) | 2 (66.7) | 3 (100) | 1 (33.3) | 0 (0) | 1 (33.3) | 3 (100) | 0 (0) | — |
| Acinetobacter spp. (n = 5) | |||||||||
| S | 5 (100) | 5 (100) | 0 (0) | 3 (60) | 5 (100) | 3 (60) | 0 (0) | 5 (100) | 3 (60) |
| R | 0 (0) | 0 (0) | 5 (100) | 2 (40) | 0 (0) | 2 (40) | 5 (100) | 0 (0) | 2 (40) |
| Total (N = 46) | |||||||||
| S | 43 (93.5) | 26 (56.5) | 4 (8.7) | 31 (67.4) | 45 (98) | 22 (47.8) | 2 (4.3) | 43 (93.5) | — |
| I | 0 (0) | 0 (0) | 0 (0) | 1 (2.1) | 0 (0) | 2 (4.3) | 2 (4.3) | 0 (0) | — |
| R | 3 (6.5) | 20 (43.5) | 42 (91.3) | 14 (30.4) | 1 ((2.2) | 22 (47.8) | 42 (91.3) | 3 (6.5) | — |
Note. CIP, ciprofloxacin; COT, cotrimoxazole; CN, gentamicin; AMP, ampicillin; AMC, amoxicillin–clavulanic acid; TE, tetracycline; CRO. ceftriaxone; C, chloramphenicol; Pi, piperacillin; S, sensitivity; I, intermediate; R, resistance.